Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 83 adverse event reports in the FDA FAERS database where AMLODIPINE was used for Psoriasis.

Most Reported Side Effects for AMLODIPINE

Side Effect Reports % Deaths Hosp.
Hypotension 6,504 10.0% 689 5,028
Toxicity to various agents 5,554 8.6% 2,601 3,827
Completed suicide 5,267 8.1% 5,254 2,025
Drug ineffective 4,091 6.3% 229 1,431
Dyspnoea 3,907 6.0% 228 1,881
Dizziness 3,536 5.5% 109 1,502
Intentional overdose 3,427 5.3% 341 2,944
Fall 3,215 5.0% 132 2,518
Fatigue 3,141 4.8% 147 1,288
Headache 2,907 4.5% 112 1,078
Drug hypersensitivity 2,880 4.4% 91 271
Hypertension 2,729 4.2% 144 1,241
Acute kidney injury 2,721 4.2% 455 2,043
Nausea 2,621 4.0% 209 1,471
Overdose 2,609 4.0% 432 2,121

Other Indications for AMLODIPINE

Product used for unknown indication (26,781) Hypertension (20,207) Blood pressure abnormal (917) Suicide attempt (714) Essential hypertension (635) Blood pressure measurement (591) Blood pressure increased (490) Coronary artery disease (486) Angina pectoris (427) Ill-defined disorder (415)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

AMLODIPINE Full Profile All Psoriasis Drugs AMLODIPINE Demographics AMLODIPINE Timeline